Jane Henderson, CFO & SVP, Corporate Development at Voyager Therapeutics, Inc. (VYGR), sold 32,732 shares at $22.15 ($724K) on 2018-03-16, disclosed to the SEC on 2018-03-20.
Open-market sale of $724k VYGR by CFO & SVP, Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.15 | 15,416 | $341K | 47.1% |
| 2 | $22.15 | 15,416 | $341K | 47.1% |
| 3 | $21.76 | 1,900 | $41K | 5.7% |
| Total | $22.13 avg | 32,732 | $724K | 100% |
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |